Price $94.37 |
Market Cap
56.3M
|
Sector Consumer Non-Cyclical |
Div. Growth
-
|
|
P/E
15.4
|
P/B
0.9
|
P/S
0.04
|
Dividend %
0.80%
|
|
P/CF
647.7
|
P/FCF
2.5
|
Op. Cash Flow
29.2K
|
FCF
37.9
|
|
Op. Margin
0.60%
|
Net Margin
0.30%
|
ROE
7.10%
|
ROI
3.80%
|
|
ROA
3.70%
|
EPS Growth
55.50%
|
Current Ratio
3.4
|
Debt/Equity
60.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MYOS RENS Technology Inc (MYOS) | $1.36 | - | - | 11.3M | Strong Buy |
| Dougherty's Pharmacy Inc (MYDP) | $0.17 | - | - | 4M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $3.05 | - | - | 34.2M | Strong Buy |
| PURE Bioscience (PURE) | $0.40 | - | - | 31.9M | Strong Buy |
| Pyxus International Inc (PYX) | $16.17 | - | - | 172.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
